Metaxalone
- Product NDC
- 69336-130
- 11-digit product format
- 693360130
- Labeler code
- 69336
- Product ID
- 69336-130_d3781696-6926-4c24-b3e3-c63542435e36
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sterling-Knight Pharmaceuticals, LLC
- Application
- ANDA207466
- Marketing category
- ANDA
- Marketing start
- 2020-06-03
- Marketing end
- 0000-00-00
- Substance
- METAXALONE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69336-130-01 | Metaxalone | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69336-130 | METAXALONE TABLET [STERLING-KNIGHT PHARMACEUTICALS, LLC] | 1 | Legacy NDC, 1 package rows | 20200604_168c539d-3637-4a43-a8b6-cd8e82cf6342.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69336-130-01 | 69336013001 | 100 TABLET in 1 BOTTLE (69336-130-01) | 100 tablet | 2020-06-03 | 0000-00-00 | No | No | Current |